References
- Brown J C. Gastric inhibitory polypeptide. Monograph of Endocrinology. Springer-Verlag, Heidelberg 1982
- Burhol P G, Jorde R, Waldum H L. Radioimmunoassay of plasma gastric inhibitory polypeptide (GIP), release of GIP after a test meal and duodenal infusion of bile, and immunoreactive plasma GIP components in man. Digestion 1980; 20: 336–45
- Cataland S, Crockett S E, Brown J C, Mazzaferri E L. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab 1974; 39: 223–8
- Thomas F B, Mazzaferri E L, Crockett S E, Mekh-jian H S, Gruemer H D, Cataland S. Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion. Gastroenterology 1976; 70: 523–7
- Dupré J, Ross S A, Watson D, Brown J C. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 1973; 37: 826–8
- Creutzfeldt W. The incretin concept today. Dia-betologia 1979; 16: 75–85
- Bloom S R. GIP in diabetes. Diabetologia 1975; 11: 334
- Crockett S E, Mazzaferri E L, Cataland S. Gastric inhibitory polypeptide in maturity-onset diabetes mellitus. Diabetes 1976; 25: 931–5
- Ebert R, Frerichs H, Creutzfeldt W. Serum gastric inhibitory polypeptide (GIP) response in patients with maturity-onset diabetes and in juvenile diabetics. Diabetologia 1976; 12: 388
- Ross S A, Brown J C, Dupre J. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus. Diabetes 1977; 26: 525–9
- Krarup T, Madsbad S, Moody A J, et al. Diminished immunoreactive gastric inhibitory polypeptide response to a test meal in newly diagnosed type 1 (insulin-dependent) diabetics. J Clin Endocrinol Metab 1983; 56: 1306–12
- Moody A J, Lauritsen K B. A sensitive radioimmunoassay for plasma GIP Abst. Gastrointestinal hormones and pathology of the digestive system, V Speranza, N Basso, E Lezoche. Arti Grafiche Tris, Rome 1977; 148–9
- Hunter W M, Greenwood F C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962; 194: 495–6
- Heding L G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabeto-logia 1972; 8: 260–6
- Heding L G. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541–8
- Unger R H, Eisentraut A M, McCall M S. Glucagon antibodies and an immunoassay for glucagon. J Clin Invest 1961; 40: 1280–9
- Alam M J, Buchanan K D. Gastric inhibitory polypeptide (GIP) responses in diabetes using three different antibodies. Regul Pept 1980; 2, Suppl. 1
- Ebert R, Creutzfeldt W. Hypo- and hypersecretion of GIP in maturity-onset diabetics. Diabetologia 1980; 19: 271
- Alam M J, Buchanan K D. Gastric inhibitory polypeptide (GIP) responses in primary diabetes. Regul Pept 1980; 2, Suppl. 1
- Elahi D, Andersen D K, Brown J C, et al. Pancreatic α- and β-celI responses to GIP infusion in normal man. Am J Physiol 1979; 237(2)E185
- Verdonk C A, Rizza R A, Nelson R L, Go V LW, Gerich J E, Service F J. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function. J Clin Invest 1980; 65: 1119–25
- Andersen D K, Elahi D, Brown J C, Tobin J D, Andres R. Oral glucose augmentation of insulin release. J Clin Invest 1978; 62: 152–61
- Sarson D L, Wood S M, Kansal P C, Bloom S R. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?. Diabetes 1984; 33: 389–93
- Service F J, Nelson R L, Rubinstein A H, Go V LW. Direct effect of insulin on secretion of insulin, glucagon, gastric inhibitory polypeptide, and gastrin during maintenance of normo-glycemia. J Clin Endocrinol Metab 1978; 47: 488–93
- Savage P J, Dippe S E, Bennett P H, et al. Hyperin-sulinemia and hypoinsulinemia. Insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes 1975; 24: 362–8
- Polonsky K S, Rubenstein A H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Diabetes 1984; 33: 486–94
- Perley M, Kipnis D M. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and non-diabetic subjects. Diabetes 1966; 15: 867–74
- Ross S A, Dupre J. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects. Diabetes 1978; 27: 327–33
- Ebert R, Unger H, Creutzfeldt W. Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption. Diabetologia 1983; 24: 449–54